Tortuga Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$762K Buy
13,228
+463
+4% +$26.6K 0.58% 46
2026
Q1
$774K Buy
12,765
+1,938
+18% +$113K 0.72% 32
2025
Q4
$584K Buy
+10,827
New +$521K 0.62% 37

Other funds holding BMY

Tortuga Wealth Management's BMY Position: Q2 2026 in Review

Tortuga Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3.6% in Q2 2026, buying an estimated $26.6K and bringing the position to 13,228 shares worth $762K. The position accounts for 0.58% of the portfolio, ranked #46.

Tortuga Wealth Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $774K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tortuga Wealth Management held 13,228 shares of Bristol-Myers Squibb worth $762K as of Q2 2026.
  • Tortuga Wealth Management bought 463 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.6K.
  • Bristol-Myers Squibb made up 0.58% of Tortuga Wealth Management's portfolio in Q2 2026, its #46 holding.
  • Tortuga Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Tortuga Wealth Management's Bristol-Myers Squibb position peaked at $774K in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tortuga Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.